Alternatively spliced fibronectin extra domain A is required for hemangiogenic recovery upon bone marrow chemotherapy
Alessandro Malara,
Cristian Gruppi,
Giuseppe Celesti,
Vittorio Abbonante,
Gianluca Viarengo,
Luigi Laghi,
Luigi De Marco,
Andrés F. Muro,
Alessandra Balduini
Affiliations
Alessandro Malara
Department of Molecular Medicine, University of Pavia, Italy;Laboratory of Biotechnology, IRCCS San Matteo Foundation, Pavia, Italy
Cristian Gruppi
Department of Molecular Medicine, University of Pavia, Italy
Giuseppe Celesti
Laboratory of Molecular Gastroenterology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy
Vittorio Abbonante
Department of Molecular Medicine, University of Pavia, Italy;Laboratory of Biotechnology, IRCCS San Matteo Foundation, Pavia, Italy
Gianluca Viarengo
Immunohaematology and Transfusion Service, Apheresis and Cell Therapy Unit, IRCCS San Matteo Foundation, Pavia, Italy
Luigi Laghi
Laboratory of Molecular Gastroenterology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy
Luigi De Marco
Department of Translational Research, National Cancer Center (IRCCS CRO), Aviano, Italy;Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA
Andrés F. Muro
The International Centre for Genetic Engineering and Biotechnology, Trieste, Italy
Alessandra Balduini
Department of Molecular Medicine, University of Pavia, Italy;Laboratory of Biotechnology, IRCCS San Matteo Foundation, Pavia, Italy;Department of Biomedical Engineering, Tufts University, Medford, MA, USA
